Does tiotropium lower exacerbation and hospitalization frequency in COPD patients: results of a meta-analysis

[1]  N. Chavannes,et al.  Exacerbations and associated healthcare cost in patients with COPD in general practice. , 2016, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[2]  M. Decramer,et al.  Tiotropium HandiHaler® in the treatment of COPD: A safety review , 2009, International journal of chronic obstructive pulmonary disease.

[3]  Lucas M Bachmann,et al.  Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis , 2009, BMC Medicine.

[4]  M. Decramer,et al.  A 4-year trial of tiotropium in chronic obstructive pulmonary disease. , 2008, The New England journal of medicine.

[5]  T. Perez,et al.  Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD , 2008, International journal of chronic obstructive pulmonary disease.

[6]  L. Nannini,et al.  Tiotropium for the treatment of stable chronic obstructive pulmonary disease: a systematic review with meta-analysis. , 2007, Pulmonary pharmacology & therapeutics.

[7]  G. Donaldson,et al.  Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD , 2007, European Respiratory Journal.

[8]  D. Price,et al.  Efficacy and safety of tiotropium in COPD patients in primary care – the SPiRiva Usual CarE (SPRUCE) study , 2007, Respiratory research.

[9]  C. Wentworth,et al.  Pooled clinical trial analysis of tiotropium safety. , 2006, Chest.

[10]  J. Bourbeau,et al.  Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis , 2006, Thorax.

[11]  D. Dusser,et al.  The effect of tiotropium on exacerbations and airflow in patients with COPD. , 2006, The European respiratory journal.

[12]  D. D. Briggs,et al.  Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD. , 2005, Pulmonary pharmacology & therapeutics.

[13]  D. Niewoehner,et al.  Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium, a Once-Daily Inhaled Anticholinergic Bronchodilator , 2005, Annals of Internal Medicine.

[14]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[15]  V. Brusasco,et al.  Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. , 2003, Thorax.

[16]  R. Zuwallack,et al.  A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease , 2002, European Respiratory Journal.

[17]  J. V. van Noord,et al.  Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium , 2002, European Respiratory Journal.

[18]  J. Bourbeau,et al.  Inhaled tiotropium for stable chronic obstructive pulmonary disease. , 2000, The Cochrane database of systematic reviews.

[19]  C. Begg,et al.  Publication bias and dissemination of clinical research. , 1989, Journal of the National Cancer Institute.

[20]  T. Seemungal,et al.  The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. , 2008, American journal of respiratory and critical care medicine.

[21]  H. Magnussen,et al.  Improvements with tiotropium in COPD patients with concomitant asthma. , 2008, Respiratory medicine.

[22]  F. Maltais,et al.  A randomized controlled trial to assess the efficacy of tiotropium in Canadian patients with chronic obstructive pulmonary disease. , 2007, Canadian respiratory journal.

[23]  P. Calverley,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[24]  C. Lenfant,et al.  Global Initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease , 2006 .

[25]  V. Brusasco,et al.  Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. , 2003, Thorax.